← FDA DRUG APPROVALS

FDA ANDA · ANDA040195

ACETAZOLAMIDE

Sponsor: TARO

APPLICATION
ANDA040195
TYPE
ANDA
ORIGINAL APPROVAL
1997-05-28
LATEST ACTION
2016-01-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ACETAZOLAMIDEPrescription
ACETAZOLAMIDE 250MG · TABLET · ORAL
ACETAZOLAMIDEPrescription
ACETAZOLAMIDE 125MG · TABLET · ORAL

Approval history

2016-01-09Labeling · Supplement 7 · standardAP
1997-05-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →